Prealize Health

Prealize Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttp://www.prealizehealth.com

Last Round

Series C

Dec 15, 2022

Total Funding Raised

$39.26M

Momentum Score

50 /100

Company Overview

Prealize Health is a healthcare technology company that provides an AI-powered predictive analytics system. Founded by industry leaders from Stanford University, the company's platform leverages machine learning to deliver insights that help health plans, providers, and employers proactively manage healthcare costs and improve patient outcomes. The system is designed to identify rising-risk individuals and the drivers of that risk, allowing clients to implement timely and effective clinical interventions. The company was formerly known as Cardinal Analytx Solutions. In 2022, Prealize Health acquired the intellectual property of CentraForce Health to enhance its data on social determinants of health.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Medical AI, InsurTech, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

predictive analyticshealthcare AIpatient risk predictionhealthcare analyticsproactive healthcarepopulation health managementpop healthrisk stratificationhealthcare cost predictionvalue-based careVBCfinancial risk managementsocial determinants of healthSDOHmember engagementhealth insurance underwritingstop-loss predictionrisk adjustment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prealize Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prealize Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CDec 15, 2022
Series BMay 23, 2019
Series ASep 27, 2017

Key People

Founding team and executive leadership

Kyle Raffaniello

CEO, Prealize Health

Executive Team

Srikannan Gopalsamy

Chief Technology Officer

Executive Team

Prealize Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 591% MoM to 815.

Prealize Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prealize Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prealize Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range36
Year Founded2016
Last FundingDec 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.